Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study.
Bickel M, Hoffmann C, Wolf E, Baumgarten A, Wyen C, Spinner CD, Jäger H, Postel N, Esser S, Mueller M, Stoehr A, Preis S, Klauke S, Schewe K; PROPHET study group of dagnae e.V.. Bickel M, et al. Among authors: wolf e. Infection. 2020 Jun;48(3):453-461. doi: 10.1007/s15010-020-01428-1. Epub 2020 May 11. Infection. 2020. PMID: 32394345 Clinical Trial.
Reply: Beyond Viral Suppression.
Spinner CD, Wolf E, Boesecke C. Spinner CD, et al. Among authors: wolf e. Open Forum Infect Dis. 2021 Feb 15;8(10):ofab073. doi: 10.1093/ofid/ofab073. eCollection 2021 Oct. Open Forum Infect Dis. 2021. PMID: 34692887 Free PMC article. No abstract available.
Switching to a NRTI-free 2 drug regimen (2DR) -a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes.
Monin M, Kümmerle T, Schneider J, Cordes C, Heiken H, Stellbrink HJ, Krznaric I, Scholten S, Jensen B, Jessen H, Obst W, Spornraft-Ragaller P, Khaykin P, Balogh A, Wolf E, Bidner H, Spinner CD, Boesecke C; DUALIS STUDY GROUP. Monin M, et al. Among authors: wolf e. HIV Res Clin Pract. 2021 Dec 23;23(1):15-21. Epub 2022 Mar 2. HIV Res Clin Pract. 2021. PMID: 35234092 Clinical Trial.
Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study.
Weidlich S, Boesecke C, Schneider J, Klinker HHF, Zink A, Balogh A, Wolf E, Bidner H, Spinner CD; DUALIS study team. Weidlich S, et al. Among authors: wolf e. J Antimicrob Chemother. 2020 Oct 1;75(10):3082-3084. doi: 10.1093/jac/dkaa234. J Antimicrob Chemother. 2020. PMID: 32634214 Free PMC article. No abstract available.
2,402 results